Abstract: A herpesvirus saimiri (HVS) vector which has inserted therein at least a part of a gene encoding an envelope protein of HIV for use in delivering said protein to a specific cell population such as T cell lymphocytes and/or macrophages. The invention also provides a vaccine comprising the recombinant vector.
Type:
Grant
Filed:
July 16, 2001
Date of Patent:
February 17, 2004
Assignee:
University of Leeds
Inventors:
David Mark Meredith, Alexander Fred Markham